Barclays’s Titan Medical Inc. Ordinary Shares TMDI Stock Holding History

Barclays’s Portfolio TMDI Stock Details TMDI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,500	Closed	-$196	–	5343
2023 Q1	$196	Buy	1,500 +500	+50%	+$288	﹤0.01%	4981
2022 Q4	$661	Hold	1,000	–	–	﹤0.01%	5140
2022 Q3	$0	Buy	1,000 +500	+100%	+$259	﹤0.01%	5278
2022 Q2	$0	Buy	+500	New	+$245	﹤0.01%	5411
2019 Q4	–	Sell	-20,987	Closed	-$23K	–	6984
2019 Q3	$23K	Buy	+20,987	New	+$43.9K	﹤0.01%	6185

Other funds holding TMDI

FHC

First Heartland Consultants Lake St. Louis, Missouri $1.55B AUM 20.5% 1-Year Est. Return

MCM

MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return

BCWM

Bartlett & Co Wealth Management Cincinnati, Ohio $7.99B AUM 20.76% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Barclays's TMDI Position: Q2 2023 in Review

Barclays sold out of Titan Medical Inc. Ordinary Shares (TMDI) in Q2 2023, closing a stake of 1,500 shares — an estimated $196 sold.

Barclays first reported a position in TMDI in Q3 2019 and held it in 5 quarters. The position peaked at $23K in Q3 2019. 5 funds tracked by Wall St. Rank hold TMDI as of Q2 2023.

Barclays reported no remaining Titan Medical Inc. Ordinary Shares position as of Q2 2023 after selling out during the quarter.
Barclays sold 1,500 Titan Medical Inc. Ordinary Shares shares in Q2 2023, an estimated $196.
Barclays first reported a position in Titan Medical Inc. Ordinary Shares in Q3 2019 and held it in 5 quarters.
Barclays's Titan Medical Inc. Ordinary Shares position peaked at $23K in Q3 2019.
5 funds tracked by Wall St. Rank held Titan Medical Inc. Ordinary Shares as of Q2 2023.

Based on Barclays's 13F filing for Q2 2023, filed 3 Aug 2023.